So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside ...

The maker of Marlboro cigarettes reports weaker-than-expected quarterly earnings.

FDA approvals and acquisitions bolster Altria's smoke-free transition. Find out why MO stock offers compelling value and ...

Altria Group, Inc. (NYSE: MO) stock is off to a strong start in 2026, up more than 7.3%. However, MO stock was down nearly 3% in midday trading on Jan. 29, as the company’s earnings were flat ...

MO and PM ramp up smoke-free growth, using pricing power and innovation to counter falling cigarette demand and reshape ...

Traders went risk off.

The tobacco titan is facing intensifying competition.

Altria is an excellent income play for long-term investors.

Altria is one of the largest cigarette makers in the United States. The company's business is in long-term decline, making its 6.9% yield highly risky for buy-and-hold investors. This "sharp shooter" ...

Altria has underperformed the S&P 500 in recent years. The stock remains a dividend powerhouse with a yield above 7%. More recently, however, the stock has struggled as cigarette sales in the U.S.

Despite offering high dividend returns at a low price, missteps and revenue declines may dampen the appeal of Altria stock.

On the surface, the tobacco giant looks too tempting to ignore. However, some tantalizing metrics may belie reasons for long-term concern. Investors must examine Altria’s dividend sustainability. 10 ...